Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Borel

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Nano Letters|September 6, 2019
Superlocalization of Excitons in Carbon Nanotubes at Cryogenic TemperatureC Raynaud, T Claude, A Borel, et al.
British Journal of Haematology|May 8, 1999
Three cases of acquired von Willebrand disease associated with systemic lupus erythematosusJ F Viallard, J L Pellegrin, C Vergnes, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 11, 2012
Hydrolysis of factor VIII mediated by catalytic antibodies occurs in haemophilia A patients with or without factor VIII inhibitorsS S Grosbois, M F Brionne, A L F de Longcamp, et al.
Schweizerische Medizinische Wochenschrift|April 30, 1983
[Dissolution of gallstones based on 6 months treatment with a single daily dose of ursodeoxycholic acid]S Realini, J J Gonvers, J Arnold, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 21, 2007
Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor VIIa in European Haemophilia CentresM Morfini, G Auerswald, R A Kobelt, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|December 5, 2009
[French guidelines. Long-term prophylaxis for severe haemophilia A and B children to prevent haemophiliac arthropathy]S Meunier, M Trossaërt, C Berger, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|January 5, 2002
Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnanciesJ Lepercq, J Conard, A Borel-Derlon, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 22, 2010
Patient resources in the therapeutic education of haemophiliacs in France: their skills and roles as defined by consensus of a working groupL Wintz, T Sannié, S Ayçaguer, et al.
Journal of Thrombosis and Haemostasis : JTH|October 1, 2005
Pharmacokinetic studies on Wilfactin, a von Willebrand factor concentrate with a low factor VIII content treated with three virus-inactivation/removal methodsJ Goudemand, I Scharrer, E Berntorp, et al.
Journal of Thrombosis and Haemostasis : JTH|April 4, 2007
Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin): a prospective study of 50 patientsA Borel-Derlon, A B Federici, V Roussel-Robert, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Nano Letters|September 6, 2019
Superlocalization of Excitons in Carbon Nanotubes at Cryogenic TemperatureC Raynaud, T Claude, A Borel, et al.
British Journal of Haematology|May 8, 1999
Three cases of acquired von Willebrand disease associated with systemic lupus erythematosusJ F Viallard, J L Pellegrin, C Vergnes, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 11, 2012
Hydrolysis of factor VIII mediated by catalytic antibodies occurs in haemophilia A patients with or without factor VIII inhibitorsS S Grosbois, M F Brionne, A L F de Longcamp, et al.
Schweizerische Medizinische Wochenschrift|April 30, 1983
[Dissolution of gallstones based on 6 months treatment with a single daily dose of ursodeoxycholic acid]S Realini, J J Gonvers, J Arnold, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 21, 2007
Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor VIIa in European Haemophilia CentresM Morfini, G Auerswald, R A Kobelt, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|December 5, 2009
[French guidelines. Long-term prophylaxis for severe haemophilia A and B children to prevent haemophiliac arthropathy]S Meunier, M Trossaërt, C Berger, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|January 5, 2002
Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnanciesJ Lepercq, J Conard, A Borel-Derlon, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 22, 2010
Patient resources in the therapeutic education of haemophiliacs in France: their skills and roles as defined by consensus of a working groupL Wintz, T Sannié, S Ayçaguer, et al.
Journal of Thrombosis and Haemostasis : JTH|October 1, 2005
Pharmacokinetic studies on Wilfactin, a von Willebrand factor concentrate with a low factor VIII content treated with three virus-inactivation/removal methodsJ Goudemand, I Scharrer, E Berntorp, et al.
Journal of Thrombosis and Haemostasis : JTH|April 4, 2007
Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin): a prospective study of 50 patientsA Borel-Derlon, A B Federici, V Roussel-Robert, et al.
Pageof 7